Search for: "Actavis Pharma"
Results 61 - 80
of 243
Sorted by Relevance
|
Sort by Date
15 Jan 2013, 11:33 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
19 Apr 2015, 4:01 pm
This year's version, subtitled "Maximising pharmaceutical patent lifecycles to foster innovation and growth", takes place at The Hotel Excelsior, Munich, from 22 to 23 June and is followed by a Masterclass on 24 June on how to draft solid pharma patent claims in light of the CJEU's rulings in Neurim, Medeva, Georgetown, Eli Lilly and Actavis v Sanofi. [read post]
29 Mar 2011, 9:19 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 Aug 2010, 12:19 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Feb 2011, 5:26 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Jan 2010, 3:32 am
Ipsen Pharma, S.A.S. et al. [read post]
28 Sep 2011, 1:56 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
26 Jan 2012, 6:57 am
Actavis appealed that verdict. [read post]
2 Nov 2011, 2:00 am
French courts give conflicting answers in preliminary injunction proceedings: Actavis v Novartis (EPLAW) Vytorin (Ezetimibe and Simvastatin) – US: Schering files patent infringement complaint against Actavis in response to Para IV certification (Patent Docs) [read post]
24 Mar 2013, 9:56 pm
Actavis (previously FTC v. [read post]
8 Apr 2012, 8:51 pm
Actavis Inc. et al. 1:12-cv-00323;... [read post]
1 Mar 2023, 1:00 am
The Supreme Court also considered it unclear whether Teva and Royalty Pharma have any influence on the interpretation of Article 3(c) (para 20). [read post]
9 Mar 2011, 3:00 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
8 Jul 2022, 3:47 am
Tris Pharma v. [read post]
23 Jan 2009, 12:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
23 Dec 2009, 12:40 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
7 Nov 2008, 3:42 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
31 Aug 2010, 10:01 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Sep 2011, 2:36 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Dec 2010, 3:01 am
Sun Pharma Global Inc. [read post]
